A previously reported clinical trial of Hypericum perforatum (St John's wort) in depression did not demonstrate efficacy. We assessed treatment adherence by measuring plasma hyperforin and evaluated the possible impact of adherence on study results.
Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial
VITIELLO, BENEDETTO;
2005-01-01
Abstract
A previously reported clinical trial of Hypericum perforatum (St John's wort) in depression did not demonstrate efficacy. We assessed treatment adherence by measuring plasma hyperforin and evaluated the possible impact of adherence on study results.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
vitiello et al.hyperforin.jcp.2005.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
99.48 kB
Formato
Adobe PDF
|
99.48 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
